Anti-stigma programs have exploded in the United States as well as across
the world in the past decade. Now needed is a more strategic approach to stigma
change, consideration of evaluation strategies that demonstrate its effectiveness.
A case study from Bosnia and Herzegovina Eurasian Harm Reduction Network
The case study was prepared by Samir Ibisevic, President of PROI between March and June 2016 and edited by Graham Shaw.
EHRN is grateful to all who contributed to this document, especially: Dr. Serifa Godinjak, Chairperson... of Country Coordinating Mechanism; Dr. Zlatko Cardaklija, HIV Coordinator for the Federation of Bosnia and Herzegovina (BiH); Dr. Nesad Seremet, Head of the HIV program, United Nations Development Program in Bosnia and Herzegovina; Ms. Gyongyver Jakab, Fund Portfolio Manager, Eastern Europe and Central Asia and Ms. Natalya Bogach, Program Officer, The Global Fund to Fight AIDS, Tuberculosis and Malaria; Dr. Nermana Mehic–Basara, Director of the Institute for Addiction Diseases of Sarajevo Canton; Mr. Denis Dedajic, Director of the Association Margina from the Federation of BiH; Mr. Srdjan Kukolj, Director of Action Against AIDS from the Republic of Srpska.
more
The primary audience of this report with the compendium of resources are youth engagement practitioners in the Red Cross Red Crescent National Societies as well as technical experts and policy makers across the humanitarian landscape that thrive for meaningful interventions with and for children, ad...olescents, and young adults experiencing the impact of the COVID-19 pandemic.
more
Strengthening HIV prevention among most-at-risk populations (MARPs) in the Syrian Arab Republic:
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...ections. Clofazimine resistance is still rare but this antimicrobial cannot be given alone
more
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
Harmonising proven strategies beyond the emergency phase. Zero Hunger Phase 2
Nature Medicine, https://doi.org/10.1038/s41591-021-01283-z
CBR Advisory Working Group | Co-ordinator: Karen Heinicke-Motsch
Science . 2020 Sep 11;369(6509):1309-1312. doi: 10.1126/science.abe2803. Epub 2020 Sep 3.
The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably
JIMSA Jan.-March 2015 Vol. 28 no.1 p.47-50e
A review of policy and practice; zero Hunger Phase 1
Research Article
PLOS ONE | https://doi.org/10.1371/journal.pone.0189770 January 2, 2018